4
DREXEL UNIVERSITY IN PHILADELPHIA OPENS MEDICAL CANNABIS RESEARCH CENTER After Pennsylvania’s medical cannabis law set forth that medical schools could be designated as Academic Clinical Research Centers (ACRC), Drexel University started operations at the Medical Cannabis Research Center in 2020, aiming to conduct clinical, public health and translational research studies along with Argonomed Biologics LLC, these two organizations entered into an 8-year, 15.5-million-dollar contract. In addition, funding for annual pilot trials is being considered in order to explore the efficacy of Cannabis as a treatment for other conditions such as autism and opioid addiction. This research center leads to the possibility of using Cannabis as a consolidated treatment for several diseases and to study on a larger scale the safety and efficacy analysis of the plant. Source: https://drexel.edu/about/glance/, https://drexel.edu/cannabis-research/about/mission-goals/
PANDEMIC ADVERSE EVENTS: UNDERDIAGNOSIS OF OTHER DISEASES, THE CASE OF TUBERCULOSIS IN AMERICA On March 24 of this year, the World Health Organization along with the Pan American Health Organization issued an alert regarding the diagnosis of tuberculosis in the American continent; due to the pandemic caused by COVID-19, a decrease of approximately 20% has been observed in the diagnosis of the disease, no information is yet available on the effect on tuberculosis-associated mortality. Tuberculosis is an infectious bacterial disease caused by Mycobacterium tuberculosis, which
primarily affects the lungs. It is and airborne disease transmitted from person to person. These bacteria are released when a person with TB in lungs or throat coughs, sneezes, talks, or sings. In 2019, approximately 290,000 new cases and 22,900 deaths were reported in America. Brazil, Peru, Mexico, Colombia, and Haiti account for 70% of the reported cases. Therefore, it is imperative to address this problem in line with the strategy of reducing deaths by tuberculosis, up to 95% by 2035.
Source: https://www.paho.org/en/news/24-3-2021-diagnosis-new-tbcases-americas-reduced-15-20-during-2020-due-pandemic
| LATEST NEWS
Written by Dr. Carmen de la Rocha D. in Plant Biotechnology, CINVESTAV-Irapuato - Master of Science in Biochemical Engineering, ITC - Bachelor of Science in Nutrition and Food Science, IBERO, León Supervisor of the Department of Development CidVID - Professor of Subject B, CUCS UdeG Member of the National System of Researchers, level I.
